MyFinsight
Home
Blog
About
Contact
biib: the balance sheet
Download
Download image
Other current assets
$916,800K
(36.02%↑ Y/Y)
Inventory
$2,209,400K
(-10.52%↓ Y/Y)
Accounts receivable, net
of allowance for...
$475,900K
(5.31%↑ Y/Y)
Accounts receivable, net
of allowance for...
$1,374,100K
(-10.55%↓ Y/Y)
Marketable securities
$97,600K
Cash and cash
equivalents
$3,862,800K
(127.33%↑ Y/Y)
Investments and other assets
$729,700K
(15.57%↑ Y/Y)
Deferred tax asset
$312,400K
(-67.75%↓ Y/Y)
Goodwill
$6,490,700K
(0.08%↑ Y/Y)
Intangible assets, net
$9,331,900K
(-4.83%↓ Y/Y)
Operating lease assets
$330,500K
(-13.12%↓ Y/Y)
Property, plant and
equipment, net
$3,075,700K
(-4.21%↓ Y/Y)
Total current assets
$8,936,600K
(30.83%↑ Y/Y)
Total assets
$29,207,500K
(3.16%↑ Y/Y)
Total liabilities and
equity
$29,207,500K
(3.16%↑ Y/Y)
Total equity
$18,207,500K
(11.30%↑ Y/Y)
Total liabilities
$11,000,000K
(-7.98%↓ Y/Y)
Treasury stock, at cost
$2,977,100K
(0.00%↑ Y/Y)
Accumulated other
comprehensive income (loss)
-$214,800K
(-47.43%↓ Y/Y)
Retained earnings
$20,601,600K
(8.47%↑ Y/Y)
Other long-term
liabilities
$761,800K
(2.38%↑ Y/Y)
Long-term operating lease
liabilities
$305,000K
(-14.57%↓ Y/Y)
Deferred tax liability
$358,100K
(-59.42%↓ Y/Y)
Notes payable
$6,285,100K
(38.26%↑ Y/Y)
Total current
liabilities
$3,290,000K
(-39.35%↓ Y/Y)
Additional paid-in capital
$797,700K
(63.30%↑ Y/Y)
Common stock, par value
0.0005 per share
$100K
(0.00%↑ Y/Y)
Accrued expense and
other
$2,773,600K
(0.67%↑ Y/Y)
Accounts payable
$413,100K
(-2.27%↓ Y/Y)
Taxes payable
$103,300K
(-79.30%↓ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
Biogen-svg
BIOGEN INC. (BIIB)
Biogen-svg
BIOGEN INC. (BIIB)